C131H141F3N36O9S — CID 159558572
6-[1-methyl-4-(3-methylimidazol-4-yl)imidazol-2-yl]-2-[4-(1-methylpyrrolidin-3-yl)anilino]-8-(2-morpholin-4-ylethyl)pyrido[2,3-d]pyrimidin-7-one;N-methyl-N-[2-[6-[5-methyl-1-(1-methylimidazol-2-yl)imidazol-4-yl]-7-oxo-2-(4-piperidin-3-ylanilino)pyrido[2,3-d]pyrimidin-8-yl]ethyl]methanesulfonamide;6-[2-methyl-4-(1-methylpyrazol-4-yl)phenyl]-2-(4-morpholin-2-ylanilino)-8-[[2-(trifluoromethyl)phenyl]methyl]pyrido[2,3-d]pyrimidin-7-one;6-[2-(1-methylpyrrol-2-yl)pyrimidin-5-yl]-8-(2-oxo-2-pyrrolidin-1-ylethyl)-2-(4-piperidin-4-ylanilino)pyrido[2,3-d]pyrimidin-7-one (PubChem CID 159558572) has the molecular formula C131H141F3N36O9S and a molecular weight of 2452.87 g/mol. Its IUPAC name is 6-[1-methyl-4-(3-methylimidazol-4-yl)imidazol-2-yl]-2-[4-(1-methylpyrrolidin-3-yl)anilino]-8-(2-morpholin-4-ylethyl)pyrido[2,3-d]pyrimidin-7-one;N-methyl-N-[2-[6-[5-methyl-1-(1-methylimidazol-2-yl)imidazol-4-yl]-7-oxo-2-(4-piperidin-3-ylanilino)pyrido[2,3-d]pyrimidin-8-yl]ethyl]methanesulfonamide;6-[2-methyl-4-(1-methylpyrazol-4-yl)phenyl]-2-(4-morpholin-2-ylanilino)-8-[[2-(trifluoromethyl)phenyl]methyl]pyrido[2,3-d]pyrimidin-7-one;6-[2-(1-methylpyrrol-2-yl)pyrimidin-5-yl]-8-(2-oxo-2-pyrrolidin-1-ylethyl)-2-(4-piperidin-4-ylanilino)pyrido[2,3-d]pyrimidin-7-one.
| Compound Name | 6-[1-methyl-4-(3-methylimidazol-4-yl)imidazol-2-yl]-2-[4-(1-methylpyrrolidin-3-yl)anilino]-8-(2-morpholin-4-ylethyl)pyrido[2,3-d]pyrimidin-7-one;N-methyl-N-[2-[6-[5-methyl-1-(1-methylimidazol-2-yl)imidazol-4-yl]-7-oxo-2-(4-piperidin-3-ylanilino)pyrido[2,3-d]pyrimidin-8-yl]ethyl]methanesulfonamide;6-[2-methyl-4-(1-methylpyrazol-4-yl)phenyl]-2-(4-morpholin-2-ylanilino)-8-[[2-(trifluoromethyl)phenyl]methyl]pyrido[2,3-d]pyrimidin-7-one;6-[2-(1-methylpyrrol-2-yl)pyrimidin-5-yl]-8-(2-oxo-2-pyrrolidin-1-ylethyl)-2-(4-piperidin-4-ylanilino)pyrido[2,3-d]pyrimidin-7-one |
|---|---|
| PubChem CID | 159558572 |
| Molecular Formula | C131H141F3N36O9S |
| Molecular Weight | 2452.87 g/mol |
| Exact Mass | 2451.14 |
| IUPAC Name | 6-[1-methyl-4-(3-methylimidazol-4-yl)imidazol-2-yl]-2-[4-(1-methylpyrrolidin-3-yl)anilino]-8-(2-morpholin-4-ylethyl)pyrido[2,3-d]pyrimidin-7-one;N-methyl-N-[2-[6-[5-methyl-1-(1-methylimidazol-2-yl)imidazol-4-yl]-7-oxo-2-(4-piperidin-3-ylanilino)pyrido[2,3-d]pyrimidin-8-yl]ethyl]methanesulfonamide;6-[2-methyl-4-(1-methylpyrazol-4-yl)phenyl]-2-(4-morpholin-2-ylanilino)-8-[[2-(trifluoromethyl)phenyl]methyl]pyrido[2,3-d]pyrimidin-7-one;6-[2-(1-methylpyrrol-2-yl)pyrimidin-5-yl]-8-(2-oxo-2-pyrrolidin-1-ylethyl)-2-(4-piperidin-4-ylanilino)pyrido[2,3-d]pyrimidin-7-one |
| SMILES | CN1CCC(c2ccc(Nc3ncc4cc(-c5nc(-c6cncn6C)cn5C)c(=O)n(CCN5CCOCC5)c4n3)cc2)C1.Cc1c(-c2cc3cnc(Nc4ccc(C5CCCNC5)cc4)nc3n(CCN(C)S(C)(=O)=O)c2=O)ncn1-c1nccn1C.Cc1cc(-c2cnn(C)c2)ccc1-c1cc2cnc(Nc3ccc(C4CNCCO4)cc3)nc2n(Cc2ccccc2C(F)(F)F)c1=O.Cn1cccc1-c1ncc(-c2cc3cnc(Nc4ccc(C5CCNCC5)cc4)nc3n(CC(=O)N3CCCC3)c2=O)cn1 |
| InChI | InChI=1S/C36H32F3N7O2.C33H35N9O2.C32H38N10O2.C30H36N10O3S/c1-22-15-24(27-18-42-45(2)20-27)9-12-29(22)30-16-26-17-41-35(43-28-10-7-23(8-11-28)32-19-40-13-14-48-32)44-33(26)46(34(30)47)21-25-5-3-4-6-31(25)36(37,38)39;1-40-14-4-5-28(40)30-35-19-25(20-36-30)27-17-24-18-37-33(38-26-8-6-22(7-9-26)23-10-12-34-13-11-23)39-31(24)42(32(27)44)21-29(43)41-15-2-3-16-41;1-38-9-8-23(19-38)22-4-6-25(7-5-22)35-32-34-17-24-16-26(30-36-27(20-39(30)2)28-18-33-21-40(28)3)31(43)42(29(24)37-32)11-10-41-12-14-44-15-13-41;1-20-26(34-19-40(20)30-32-12-13-37(30)2)25-16-23-18-33-29(35-24-9-7-21(8-10-24)22-6-5-11-31-17-22)36-27(23)39(28(25)41)15-14-38(3)44(4,42)43/h3-12,15-18,20,32,40H,13-14,19,21H2,1-2H3,(H,41,43,44);4-9,14,17-20,23,34H,2-3,10-13,15-16,21H2,1H3,(H,37,38,39);4-7,16-18,20-21,23H,8-15,19H2,1-3H3,(H,34,35,37);7-10,12-13,16,18-19,22,31H,5-6,11,14-15,17H2,1-4H3,(H,33,35,36) |
| InChIKey | MGHRHXTWAINSCW-UHFFFAOYSA-N |
| XLogP | 16.60 |
| TPSA | 477.77 Ų |
| H-Bond Donors | 7 |
| H-Bond Acceptors | 43 |
| Rotatable Bonds | 31 |
| Heavy Atoms | 180 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2452.87 |
| LogP ≤ 5 | 16.60 |
| H-Bond Donors ≤ 5 | 7 |
| H-Bond Acceptors ≤ 10 | 43 |